紫光股份(000938.SZ):近幾日林芝清創通過集中競價共減持2000萬股
格隆匯5月26日丨紫光股份(000938.SZ)公佈,2021年5月26日,公司收到林芝清創發來的《關於股份減持進展情況的吿知函》,截至2021年5月26日,上述減持計劃已實施完畢,且林芝清創自2020年10月12日至2021年5月26日累計減持公司股份超過公司總股本的1%。
2021年5月20日-2021年5月26日,林芝清創通過集中競價交易方式共減持公司2000萬股股份,佔公司總股本的0.70%,減持價格區間為17.90元—19.13元。
林芝清創及其一致行動人於2020年9月16日向公司出具了《簡式權益變動報吿書》。自2020年9月17日至2021年5月26日,林芝清創累計減持公司股份3204.1068萬股,減持比例為1.12%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.